Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor β type II receptor expression in human pancreatic cancer cells

Shujie Zhao, Kolaparthi Venkatasubbarao, Senlin Li, James W Freeman

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

In this study, we demonstrate a novel mechanism by which down-regulation of transforming growth factor β type II receptor (TβRII) is mediated by a histone deacetylase (HDAC) in pancreatic ductal adenocarcinoma (PDAC) cells. Treatment of PDAC cell lines BxPC-3 and MIA PaCa-2 with a specific HDAC inhibitor, trichostatin A (TSA), strongly activates TβRII promoter activity and induces TβRII expression. The transcriptional activation of TβRII by TSA was correlated with a decrease in HDAC activity and an increase in acetylated histone H4 protein. Correspondingly, an increase in the association of TβRII promoter with acetylated histone H4 was detected in the TSA-treated cells as determined by a chromatin immunoprecipitation assay. We found that a specific Sp1 site (Sp1C, located at -102 bp relative to the transcription start site) adjacent to an inverted CCAAT box (-83 bp) is required for TSA-mediated activation of the TβRII promoter. Furthermore, we determined that HDAC1 complexed with Sp1 in PDAC cells and that TSA treatment interfered with this association. Diminished binding of HDAC1 to the -112 to -65 bp region of the TβRII promoter after TSA treatment was confirmed by a DNA affinity precipitation assay. This is the first study to demonstrate the requirement of a specific Sp1 site for TSA-mediated transcriptional activation of TβRII. This study further suggests that the specificity of this Sp1 site for HDAC-mediated repression of TβRII may involve the interaction of the Sp1-HDAC1 complex with components of the cognate transcriptional regulators that bind to the inverted CCAAT box.

Original languageEnglish (US)
Pages (from-to)2624-2630
Number of pages7
JournalCancer Research
Volume63
Issue number10
StatePublished - May 15 2003

Fingerprint

trichostatin A
Histone Deacetylases
Growth Factor Receptors
Transforming Growth Factors
Pancreatic Neoplasms
Adenocarcinoma
Histones
Transcriptional Activation
Histone Deacetylase Inhibitors
Chromatin Immunoprecipitation
Transcription Initiation Site
Genetic Promoter Regions
Down-Regulation
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor β type II receptor expression in human pancreatic cancer cells. / Zhao, Shujie; Venkatasubbarao, Kolaparthi; Li, Senlin; Freeman, James W.

In: Cancer Research, Vol. 63, No. 10, 15.05.2003, p. 2624-2630.

Research output: Contribution to journalArticle

@article{1411e56ab46d42b680b092d276659036,
title = "Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor β type II receptor expression in human pancreatic cancer cells",
abstract = "In this study, we demonstrate a novel mechanism by which down-regulation of transforming growth factor β type II receptor (TβRII) is mediated by a histone deacetylase (HDAC) in pancreatic ductal adenocarcinoma (PDAC) cells. Treatment of PDAC cell lines BxPC-3 and MIA PaCa-2 with a specific HDAC inhibitor, trichostatin A (TSA), strongly activates TβRII promoter activity and induces TβRII expression. The transcriptional activation of TβRII by TSA was correlated with a decrease in HDAC activity and an increase in acetylated histone H4 protein. Correspondingly, an increase in the association of TβRII promoter with acetylated histone H4 was detected in the TSA-treated cells as determined by a chromatin immunoprecipitation assay. We found that a specific Sp1 site (Sp1C, located at -102 bp relative to the transcription start site) adjacent to an inverted CCAAT box (-83 bp) is required for TSA-mediated activation of the TβRII promoter. Furthermore, we determined that HDAC1 complexed with Sp1 in PDAC cells and that TSA treatment interfered with this association. Diminished binding of HDAC1 to the -112 to -65 bp region of the TβRII promoter after TSA treatment was confirmed by a DNA affinity precipitation assay. This is the first study to demonstrate the requirement of a specific Sp1 site for TSA-mediated transcriptional activation of TβRII. This study further suggests that the specificity of this Sp1 site for HDAC-mediated repression of TβRII may involve the interaction of the Sp1-HDAC1 complex with components of the cognate transcriptional regulators that bind to the inverted CCAAT box.",
author = "Shujie Zhao and Kolaparthi Venkatasubbarao and Senlin Li and Freeman, {James W}",
year = "2003",
month = "5",
day = "15",
language = "English (US)",
volume = "63",
pages = "2624--2630",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor β type II receptor expression in human pancreatic cancer cells

AU - Zhao, Shujie

AU - Venkatasubbarao, Kolaparthi

AU - Li, Senlin

AU - Freeman, James W

PY - 2003/5/15

Y1 - 2003/5/15

N2 - In this study, we demonstrate a novel mechanism by which down-regulation of transforming growth factor β type II receptor (TβRII) is mediated by a histone deacetylase (HDAC) in pancreatic ductal adenocarcinoma (PDAC) cells. Treatment of PDAC cell lines BxPC-3 and MIA PaCa-2 with a specific HDAC inhibitor, trichostatin A (TSA), strongly activates TβRII promoter activity and induces TβRII expression. The transcriptional activation of TβRII by TSA was correlated with a decrease in HDAC activity and an increase in acetylated histone H4 protein. Correspondingly, an increase in the association of TβRII promoter with acetylated histone H4 was detected in the TSA-treated cells as determined by a chromatin immunoprecipitation assay. We found that a specific Sp1 site (Sp1C, located at -102 bp relative to the transcription start site) adjacent to an inverted CCAAT box (-83 bp) is required for TSA-mediated activation of the TβRII promoter. Furthermore, we determined that HDAC1 complexed with Sp1 in PDAC cells and that TSA treatment interfered with this association. Diminished binding of HDAC1 to the -112 to -65 bp region of the TβRII promoter after TSA treatment was confirmed by a DNA affinity precipitation assay. This is the first study to demonstrate the requirement of a specific Sp1 site for TSA-mediated transcriptional activation of TβRII. This study further suggests that the specificity of this Sp1 site for HDAC-mediated repression of TβRII may involve the interaction of the Sp1-HDAC1 complex with components of the cognate transcriptional regulators that bind to the inverted CCAAT box.

AB - In this study, we demonstrate a novel mechanism by which down-regulation of transforming growth factor β type II receptor (TβRII) is mediated by a histone deacetylase (HDAC) in pancreatic ductal adenocarcinoma (PDAC) cells. Treatment of PDAC cell lines BxPC-3 and MIA PaCa-2 with a specific HDAC inhibitor, trichostatin A (TSA), strongly activates TβRII promoter activity and induces TβRII expression. The transcriptional activation of TβRII by TSA was correlated with a decrease in HDAC activity and an increase in acetylated histone H4 protein. Correspondingly, an increase in the association of TβRII promoter with acetylated histone H4 was detected in the TSA-treated cells as determined by a chromatin immunoprecipitation assay. We found that a specific Sp1 site (Sp1C, located at -102 bp relative to the transcription start site) adjacent to an inverted CCAAT box (-83 bp) is required for TSA-mediated activation of the TβRII promoter. Furthermore, we determined that HDAC1 complexed with Sp1 in PDAC cells and that TSA treatment interfered with this association. Diminished binding of HDAC1 to the -112 to -65 bp region of the TβRII promoter after TSA treatment was confirmed by a DNA affinity precipitation assay. This is the first study to demonstrate the requirement of a specific Sp1 site for TSA-mediated transcriptional activation of TβRII. This study further suggests that the specificity of this Sp1 site for HDAC-mediated repression of TβRII may involve the interaction of the Sp1-HDAC1 complex with components of the cognate transcriptional regulators that bind to the inverted CCAAT box.

UR - http://www.scopus.com/inward/record.url?scp=0038519756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038519756&partnerID=8YFLogxK

M3 - Article

C2 - 12750289

AN - SCOPUS:0038519756

VL - 63

SP - 2624

EP - 2630

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 10

ER -